Fine Foods & Pharmaceuticals N T M S p A : H1-2023 RESULTS PRESENTATION

H1 2023

RESULTS PRESENTATION

14/09/23

FINE FOODS

H1 2023

RESULTS PRESENTATION

INDEX

2

INDEX

WE CREATE	FINANCIALS	SHAREHOLDING
VALUE		STRUCTURE

INVESTOR	BACK UP
INFORMATION	ESG DETAILS
& CONTACTS

FINE FOODS

H1 2023	DISCLAIMER	3
RESULTS PRESENTATION

Disclaimer

This document has been prepared by Fine Foods & Pharmaceuticals N.T.M. S.p.A. for the sole purpose described herein. The information herein is provided on a strictly confidential basis. By receiving this document the recipient undertakes with the Company to maintain the contents of the document and the document itself strictly confidential. This document may not be copied, distributed or reproduced in whole or in part, nor passed to any third party without the written consent of the Company.

The information contained herein does not purport to be comprehensive. The content of this document has a merely informative nature and is not to be construed as providing investment advice. Interested parties should conduct their own investigation and analysis of the Company and the data set forth in this document.

The statements contained herein have not been independently verified. No representation or warranty, either express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, ompleteness, correctness or reliability of the information contained herein. Neither the Company nor any of its representatives shall accept any liability whatsoever (whether in negligence or otherwise) arising in any way in relation to such information or in relation to any loss arising from its use or otherwise arising in connection with this presentation.

The information contained in this document, unless otherwise specified is only current as of the date of this document. Unless otherwise stated in this document, the information contained herein is based on management information and estimates.

This presentation includes certain forward looking statements, projections, objectives and estimates reflecting the current views of the management of the Company with respect to future events. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements as a prediction of actual results.

All forward-looking statements included herein are based on information available to the Company as of the date hereof. The Company undertakes no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law. The information contained herein is subject to change without notice and past performance is not indicative of future results. The Company may alter, modify or otherwise change in any manner the content of this document, without obligation to notify any person of such revision or changes.

FINE FOODS

H1 2023

4

RESULTS PRESENTATION

WE CREATE

VALUE

FINE FOODS

H1 2023	WE CREATE VALUE	5
RESULTS PRESENTATION

Fine Foods at a glance

Italian independent CDMO working in the pharmaceutical, nutraceutical and cosmetics industries with three integrated Business Units

Listed on Borsa Italiana's Euronext STAR Milan (Ticker: FF)

206.9 €M Revenues in 2022 with ~10% CAGR over the last 10 years

• 750 employees (+59% over the last 5 years) of which ~16%

dedicated to R&D and QA

Strong partnership with multinational clients in all our reference markets

Stable presence of Eigenfin S.r.l. and Marco Eigenmann in the shareholding structure

87.3 €M increase in revenues over the last 5 years (+73%)

• 60,000 sqm of covered area on a total area of more than 200,000 sqm